Enveric Biosciences, Inc. Common Stock (ENVB) is a publicly traded Healthcare sector company. As of July 28, 2026, ENVB trades at $1.30 with a market cap of $5.20M and a P/E ratio of -0.04. ENVB moved +0.00% today. Year to date, ENVB is -63.09%; over the trailing twelve months it is -91.48%. Its 52-week range spans $1.25 to $96.30. Rallies surfaces ENVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ENVB combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.30 |
| Market Cap | $5.20M |
| P/E Ratio | -0.04 |
| EPS | $-36.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $96.30 |
| 52-Week Low | $1.25 |
| Volume | 8.15K |
| Avg Volume | 0 |
| Revenue (TTM) | $-106 |
| Net Income | $-8.77M |
| Gross Margin | 0.00% |
ENVB analyst coverage data. Average price target: $0.00.